Apparently, this stock can and WILL move without news. Heck, as far as I can tell, the recent news, that their main competitor's drug is inferior, was very positive, yet carnage ensues. "The Market" somehow didn't like that the competition is inferior? Clearly this baby can and does move even without news.
Wall Street Players - and more and more each day - want a piece of the action - Sarepta. And you can now expect the game to be played ruthlessly by the the masters of the game. That's where we are now. The cat is out of the bag. The light has been spotted coming out from under our barrel - and everybody now wants their piece. This madness should go on for a long long time. We hope!